Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sage Therapeutics, Inc announces pricing of initial public offering


Thursday, 17 Jul 2014 06:54pm EDT 

Sage Therapeutics, Inc:Announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $18.00 per share, before underwriting discounts.Says all of the common stock is being offered by SAGE.Says in addition, SAGE has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock from SAGE at the public offering price to cover over-allotments, if any.Says the company's shares are expected to begin trading on the NASDAQ Global Market on July 18, 2014 under the ticker symbol SAGE.Says J.P. Morgan Securities LLC and Goldman, Sachs & Co. are acting as joint book-running managers.Says Leerink Partners LLC is acting as lead manager and Canaccord Genuity Inc. is acting as co-manager. 

Company Quote

40.19
-0.13 -0.32%
19 Dec 2014